328 related articles for article (PubMed ID: 30393107)
21. The adapter protein c-Cbl-associated protein (CAP) protects from acute CVB3-mediated myocarditis through stabilization of type I interferon production and reduced cytotoxicity.
Valaperti A; Nishii M; Liu Y; Yang H; Naito K; Liu PP; Eriksson U
Basic Res Cardiol; 2014 May; 109(3):411. PubMed ID: 24763933
[TBL] [Abstract][Full Text] [Related]
22. Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy.
Westermann D; Savvatis K; Lindner D; Zietsch C; Becher PM; Hammer E; Heimesaat MM; Bereswill S; Völker U; Escher F; Riad A; Plendl J; Klingel K; Poller W; Schultheiss HP; Tschöpe C
Circulation; 2011 Nov; 124(19):2082-93. PubMed ID: 21986287
[TBL] [Abstract][Full Text] [Related]
23. The protection effects of survivin in the cell model of CVB3-induced viral myocarditis.
Wu R; Wu T; Li P; Wang Q; Shi Y; Zhan Y; Zhang S; Xia T; Wang Z; Lv H
Heart Vessels; 2020 Aug; 35(8):1171-1179. PubMed ID: 32328712
[TBL] [Abstract][Full Text] [Related]
24. MiR-223/Pknox1 axis protects mice from CVB3-induced viral myocarditis by modulating macrophage polarization.
Gou W; Zhang Z; Yang C; Li Y
Exp Cell Res; 2018 May; 366(1):41-48. PubMed ID: 29524390
[TBL] [Abstract][Full Text] [Related]
25. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice.
Glück B; Schmidtke M; Merkle I; Stelzner A; Gemsa D
J Mol Cell Cardiol; 2001 Sep; 33(9):1615-26. PubMed ID: 11549341
[TBL] [Abstract][Full Text] [Related]
26. Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas.
Pinkert S; Pryshliak M; Pappritz K; Knoch K; Hazini A; Dieringer B; Schaar K; Dong F; Hinze L; Lin J; Lassner D; Klopfleisch R; Solimena M; Tschöpe C; Kaya Z; El-Shafeey M; Beling A; Kurreck J; Van Linthout S; Klingel K; Fechner H
Cardiovasc Res; 2020 Aug; 116(10):1756-1766. PubMed ID: 31598635
[TBL] [Abstract][Full Text] [Related]
27. Platelets interact with Coxsackieviruses B and have a critical role in the pathogenesis of virus-induced myocarditis.
Negrotto S; Jaquenod de Giusti C; Rivadeneyra L; Ure AE; Mena HA; Schattner M; Gomez RM
J Thromb Haemost; 2015 Feb; 13(2):271-82. PubMed ID: 25393316
[TBL] [Abstract][Full Text] [Related]
28. Coxsackievirus B3-induced myocarditis in MHC class II-deficient mice.
Leipner C; Borchers M; Merkle I; Stelzner A
J Hum Virol; 1999; 2(2):102-14. PubMed ID: 10225212
[TBL] [Abstract][Full Text] [Related]
29. Macrophage NLRP3 inflammasome activated by CVB3 capsid proteins contributes to the development of viral myocarditis.
Bao J; Sun T; Yue Y; Xiong S
Mol Immunol; 2019 Oct; 114():41-48. PubMed ID: 31336248
[TBL] [Abstract][Full Text] [Related]
30. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
[TBL] [Abstract][Full Text] [Related]
31. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis.
Li K; Xu W; Guo Q; Jiang Z; Wang P; Yue Y; Xiong S
Circ Res; 2009 Aug; 105(4):353-64. PubMed ID: 19608981
[TBL] [Abstract][Full Text] [Related]
32. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
[TBL] [Abstract][Full Text] [Related]
33. [The mechanisms responsible for the therapeutic effects of anti-Fas ligand antibody on viral myocarditis in mice].
Chang H; Han B; Han XZ
Zhonghua Er Ke Za Zhi; 2005 Dec; 43(12):920-4. PubMed ID: 16412356
[TBL] [Abstract][Full Text] [Related]
34. MicroRNAs regulate the pathogenesis of CVB3-induced viral myocarditis.
Zhang Q; Xiao Z; He F; Zou J; Wu S; Liu Z
Intervirology; 2013; 56(2):104-13. PubMed ID: 23183417
[TBL] [Abstract][Full Text] [Related]
35. Cardiac fibroblasts aggravate viral myocarditis: cell specific coxsackievirus B3 replication.
Lindner D; Li J; Savvatis K; Klingel K; Blankenberg S; Tschöpe C; Westermann D
Mediators Inflamm; 2014; 2014():519528. PubMed ID: 25374444
[TBL] [Abstract][Full Text] [Related]
36. Coxsackievirus B3 induces viral myocarditis by upregulating toll-like receptor 4 expression.
Zhao Z; Cai TZ; Lu Y; Liu WJ; Cheng ML; Ji YQ
Biochemistry (Mosc); 2015 Apr; 80(4):455-62. PubMed ID: 25869363
[TBL] [Abstract][Full Text] [Related]
37. Remission of CVB3-induced viral myocarditis by in vivo Th2 polarization via hydrodynamics-based interleukin-4 gene transfer.
Jiang Z; Xu W; Li K; Yue Y; Xu L; Ye F; Xiong S
J Gene Med; 2008 Aug; 10(8):918-29. PubMed ID: 18512734
[TBL] [Abstract][Full Text] [Related]
38. Development of a enterovirus diagnostic assay system for diagnosis of viral myocarditis in humans.
Lim BK; Ju ES; Lao DH; Yun SH; Lee YJ; Kim DK; Jeon ES
Microbiol Immunol; 2013 Apr; 57(4):281-7. PubMed ID: 23586632
[TBL] [Abstract][Full Text] [Related]
39. Crocetin Exerts a Cardio-protective Effect on Mice with Coxsackievirus B3-induced Acute Viral Myocarditis.
Qin L; Liu H; Wang J; Wang W; Zhang L
J Oleo Sci; 2021; 70(8):1115-1124. PubMed ID: 34349088
[TBL] [Abstract][Full Text] [Related]
40. CX3CR1 knockout aggravates Coxsackievirus B3-induced myocarditis.
Müller I; Pappritz K; Savvatis K; Puhl K; Dong F; El-Shafeey M; Hamdani N; Hamann I; Noutsias M; Infante-Duarte C; Linke WA; Van Linthout S; Tschöpe C
PLoS One; 2017; 12(8):e0182643. PubMed ID: 28800592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
